The surprise event was organised to mark the Abu Dhabi Mobility Week (ADMW) that is underway till May 1
The World Health Organisation (WHO) has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech’s Covid-19 vaccine, Covaxin.
Earlier, the WHO panel had sought additional clarifications from the manufacturer of Covaxin to conduct a final EUL risk-benefit assessment for global use of the vaccine.
The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a Covid19 vaccine can be listed for emergency use under the EUL procedure.
Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic Covid-19 and 65.2 per cent protection against the new Delta variant. Bharat Biotech said that it concluded the final analysis of Covaxin efficacy from Phase 3 trials.
Bharat Biotech’s Covaxin and AstraZeneca and Serum Institute’s Covishield are the two widely used vaccines in India.
Meanwhile, India’s cumulative vaccination coverage crossed 1,07 billion.
The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson - Janssen, Moderna, and Sinopharm for emergency use.
The surprise event was organised to mark the Abu Dhabi Mobility Week (ADMW) that is underway till May 1
In total, 94 nationalities invested in Sharjah during the first quarter of 2024
The Parisians are on 69 points with four games left with Monaco trailing by 11 points
The health ministry has ensured the safety of 'a very limited number' of people who showed some symptoms of being affected by 'the mixed water'
The evening was a resounding success, boasting delectable cuisine, a lively ambiance, and impeccable service
Reds defeat at Everton extinguishes their last hopes of winning the Premier League
The destination was to originally close on April 28
The cashback is valid until May 12